327 companies
AGTC
Applied Genetic Technologies Corp
Applied Genetic Technologies Corp.
Florida
NASDAQ
APTO
Aptose Biosciences Inc.
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States.
Ontario, Canada
NASDAQ
ACLX
Arcellx, Inc.
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases.
California
NASDAQ
ARMP
Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide.
California
AMEX
ARTV
Artiva Biotherapeutics, Inc. Common Stock
California
NASDAQ
ATRA
Atara Biotherapeutics, Inc.
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States.
California
NASDAQ
ATHA
Athira Pharma, Inc.
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation.
Washington
NASDAQ
Audentes Therapeutics, Inc.
Audentes Therapeutics, Inc.
California
AURA
Aura Biosciences, Inc.
Aura Biosciences, Inc.
Massachusetts
NASDAQ
AURN
Aurion Biotech, Inc.
Washington
NYSE
AUTL
Autolus Therapeutics plc
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer.
United Kingdom
NASDAQ
ALBT
Avalon GloboCare Corp.
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and the People's Republic of China.
New Jersey
NASDAQ
AXLA
Axcella Health Inc.
axcella has pioneered a new therapeutic class – defined amino acid compositions (daacs™). our daac therapeutics leverage the essential signaling function of amino acids to restore health across a network of dysregulated pathways, and provide safer solutions for patients with complex disease.
Massachusetts
NASDAQ
BEAM
Beam Therapeutics Inc.
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States.
Massachusetts
NASDAQ
TECH
Bio-Techne Corporation
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide.
Minnesota
NASDAQ
BCAB
BioAtla, Inc.
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.
California
NASDAQ
BCDA
BioCardia, Inc.
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases.
California
NASDAQ
BCRX
BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines.
North Carolina
NASDAQ
SAVU
BioLife4D Corp
Illinois
NASDAQ
BNTX
BioNTech SE
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases.
Germany
NASDAQ